Applied Therapeutics Inc.
02/13/2026 | Press release | Distributed by Public on 02/13/2026 07:30
Termination Notice (Form 15-12G)
As filed with the Securities and Exchange Commission on February 13, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-38898
Applied Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
545 Fifth Avenue, Suite 1400
New York, NY 10017
(Address, including zip code of registrant's principal executive offices)
Common stock, $0.0001 par value per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1) |
☒ | |
|
Rule 12g-4(a)(2) |
☐ | |
|
Rule 12h-3(b)(1)(i) |
☒ | |
|
Rule 12h-3(b)(1)(ii) |
☐ | |
|
Rule 15d-6 |
☐ | |
|
Rule 15d-22(b) |
☐ |
Approximate number of holders of record as of the certification or notice date: One (1).*
| * |
Explanatory Note: Pursuant to the Agreement and Plan of Merger, dated as of December 11, 2025, by and among Cycle Group Holdings Limited, a private limited company incorporated in England and Wales ("Parent"), AT2B, Inc., a Delaware corporation and indirect wholly owned subsidiary of Parent ("Purchaser") and Applied Therapeutics, Inc., a Delaware Corporation (the "Company"), Purchaser merged with and into the Company with the Company surviving the merger as an indirect wholly owned subsidiary of Parent. The merger became effective on February 3, 2026, upon the filing of the certificate of merger with the Secretary of State of the State of Delaware. |
Pursuant to the requirements of the Securities Exchange Act of 1934, Applied Therapeutics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: February 13, 2026
| APPLIED THERAPEUTICS, INC | ||
| By: | /s/ James Harrison | |
| Name: | James Harrison | |
| Title: | President | |
Applied Therapeutics Inc. published this content on February 13, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 13, 2026 at 13:30 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]